Repare Therapeutics (RPTX)
(Real Time Quote from BATS)
$1.54 USD
+0.01 (0.65%)
Updated Aug 7, 2025 03:30 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Repare Therapeutics Inc. has a market cap of $65.62M, which represents its share price of $1.53 multiplied by its outstanding shares number of 42.89M. As a small-cap company, RPTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RPTX 1.54 +0.01(0.65%)
Will RPTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RPTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPTX
CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates
What Makes Repare Therapeutics (RPTX) a New Buy Stock
RPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Myriad Genetics (MYGN) Meets Q4 Earnings Estimates
Repare Therapeutics (RPTX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Repare Therapeutics (RPTX) Loses -5.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Other News for RPTX
Repare Therapeutics Jumps 15% After $10M Licensing Deal With Debiopharm
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Why Data Storage Shares Are Trading Higher By 35%; Here Are 20 Stocks Moving Premarket
Closing Bell Movers: Victory Capital gains on S&P 400 inclusion
12 Health Care Stocks Moving In Tuesday's After-Market Session